A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination
Clinical trial NCT04797923 · UNKNOWN
Trial details
- NCT number
- NCT04797923
- Sponsor
- Gangnam Severance Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2021-06-30
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.